Palo Alto Investors’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Palo Alto Investors’s Portfolio PKBO Stock Details PKBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-497,528	Closed	-$314K	–	32
2023 Q1	$314K	Hold	497,528	–	–	0.03%	29
2022 Q4	$2.02M	Buy	+497,528	New	+$3.46M	0.17%	23

Palo Alto Investors's PKBO Position: Q2 2023 in Review

Palo Alto Investors sold out of Peak Bio, Inc. Common Stock (PKBO) in Q2 2023, closing a stake of 497,528 shares — an estimated $314K sold.

Palo Alto Investors first reported a position in PKBO in Q4 2022 and held it in 2 quarters. The position peaked at $2.02M in Q4 2022. 0 funds tracked by Wall St. Rank hold PKBO as of Q2 2023.

Palo Alto Investors reported no remaining Peak Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Palo Alto Investors sold 497,528 Peak Bio, Inc. Common Stock shares in Q2 2023, an estimated $314K.
Palo Alto Investors first reported a position in Peak Bio, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Palo Alto Investors's Peak Bio, Inc. Common Stock position peaked at $2.02M in Q4 2022.
0 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q2 2023.

Based on Palo Alto Investors's 13F filing for Q2 2023, filed 14 Aug 2023.